Artificial Cell Technologies
Chemicals & Related Products · Connecticut, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
5 Science Park Ste 13, New Haven, Connec...Phone Number
(203) 772-3430Website
www.artificialcelltech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Artificial Cell Technologies
Artificial Cell Technologies, Inc. (ACT) is a biotechnology company based in New Haven, CT, focused on developing synthetic vaccines using a proprietary technology platform of ultra-thin multilayer polypeptide nanofilms. ACT aims to revolutionize vaccine manufacturing by producing multi-valent vaccines rapidly and on-demand, making them more accessible and cost-effective, particularly for developing regions. Their product pipeline includes vaccines for Respiratory Syncytial Virus (RSV) and malaria, both of which are in pre-clinical development. By utilizing decentralized manufacturing, ACT seeks to improve vaccine distribution and administration, ultimately saving lives.Explore more
Artificial Cell Technologies Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Artificial Cell Technologies your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Artificial Cell Technologies is spiking on competitors!
Funding: Get notified immidiatlly once Artificial Cell Technologies has new funding data
Click to see if Artificial Cell Technologies had a recent Job posting/layoffs
Artificial Cell Technologies, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Artificial Cell Technologies has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Artificial Cell Technologies recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Artificial Cell Technologies
Product Launch: Get notified when Artificial Cell Technologies launches new products
Recommended Actions
Find VP level buyers at Artificial Cell Technologies
Find 3 more new buyers
Compare Similar Companies to Artificial Cell Technologies
Compare insights from companies similar to Artificial Cell Technologies, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Artificial Cell Technologies is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Artificial Cell Technologies is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Artificial Cell Technologies.
Artificial Cell Technologies Tech Stack
A closer look at the technologies used by Artificial Cell Technologies
Artificial Cell Technologies News & Media
Read more news
Top Chemicals & Related Products Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Artificial Cell Technologies
Sign Up For FreeTo access detailed company insights
Artificial Cell Technologies, Inc. (ACT) is a biotechnology company based in New Haven, CT, focused on developing synthetic vaccines using a proprietary technology platform of ultra-thin multilayer polypeptide nanofilms. ACT aims to revolutionize vaccine manufacturing by producing multi-valent vaccines rapidly and on-demand, making them more access... Read More
